SECURITIES AND EXCHANGE COMMISSION

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report: December 2, 2003
Date of earliest event reported: December 2, 2003

 

 

PFIZER INC.
(Exact name of registrant as specified in its charter)

Delaware

1-3619

13-5315170

(State or other Jurisdiction of incorporation)

(Commission File Number)

(I.R.S. Employer
Identification No.)

 

235 East 42nd Street
New York, New York

10017
(Zip Code)

(Address of principal executive offices)

 

Registrant's telephone number, including area code:

(212) 573-2323

 

Item 5. Other Events and Regulation FD Disclosure

On December 2, 2003, Pfizer Inc. and Mellon Investor Services LLC (successor to ChaseMellon Shareholder Services L.L.C.) agreed to amend the Rights Agreement that they had entered into on October 6, 1997 (the "Agreement") to change the Final Expiration Date, as defined in the Agreement, to December 31, 2003. A copy of Amendment No. 1 to the Agreement is included as Exhibit 99 to this report and is incorporated herein by reference.

Item 7(c).

 

Exhibits

Exhibit 99

-

Amendment No. 1 dated December 2,2003, to the Rights Agreement dated October 6, 1997 between Pfizer Inc. and Mellon Investor Services LLC (successor to ChaseMellon Shareholder Services L.L.C.)

 

 

SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.

 

 

PFIZER INC.

 

By: /s/Margaret M. Foran
____________________________
Margaret M. Foran
Title: Vice President-Corporate
Governance and Secretary

 

 

 

Dated: December 2, 2003

 

EXHIBIT INDEX

Exhibit No.

Description

99

Amendment No. 1 dated December 2, 2003, to the Rights Agreement dated October 6, 1997 between Pfizer Inc. and Mellon Investor Services LLC (successor to ChaseMellon Shareholder Services L.L.C.)